200
Participants
Start Date
December 18, 2018
Primary Completion Date
August 4, 2023
Study Completion Date
September 30, 2023
HPLC-MS/MS-guided intervention
The HPLC-MS/MS-guided intervention consists of providing partially or totally non-adherent hypertensive patients with information on the results of their HPLC-MS/MS-based urine analysis combined with tailored targeting of the main reason(s) for the deviation from the prescribed antihypertensive treatment
Standard care
Standard care for hypertensive patients
University College London Hospitals NHS Foundation Trust, London
Homerton Hospital, London
St Bartholomews Hospital, London
Manchester Royal Infirmary, Manchester
Ninewells Hospital, Dundee
Alvaston Medical Centre, Derby
Epsom & St. Helier University Hospitals NHS Trust, Epsom
Glenfield General Hospital, Leicester
Royal Free Hospital, London
Guy's and St Thomas' Hospital, London
Chilwell Valley and Meadows Practice, Nottingham
University Hospitals Dorset NHS Foundation Trust, Poole
Collaborators (1)
British Heart Foundation
OTHER
Manchester Academic Health Science Centre
OTHER
Omron Healthcare Co., Ltd.
INDUSTRY
University of Manchester
OTHER